Insider · CIK 0001636994
Brian Adams
Files at RLAY (Relay Therapeutics, Inc.), KYMR (Kymera Therapeutics, Inc.). First filing Oct 30, 2024, latest Sep 4, 2026.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
RLAY: Relay Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
KYMR: Kymera Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | KYMRsell Kymera Therapeutics, Inc. | $744k 6,371 shares | -11% | - | |
| 38Weak | Relay Therapeutics, Inc. | $73k 19,913 shares | -5% | +85% from low-54% from high | |
| 36Weak | Relay Therapeutics, Inc. | $44k 14,587 shares | -4% | +63% from low-60% from high | |
| 30Weak | Relay Therapeutics, Inc. | $846 298 shares | -0% | +5% from low-63% from high | |
| 48Moderate | Relay Therapeutics, Inc. | $248k 54,479 shares | -17% | +21% from low-43% from high | |
| 30Weak | Relay Therapeutics, Inc. | $1,310 299 shares | -0% | - | |
| 30Weak | Relay Therapeutics, Inc. | $9,890 1,632 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 4, 2026 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock | -1,209 | $115.55 | $140k | 55,416 | 38 d ago |
| Sep 4, 2026 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock | -3,025 | $116.81 | $353k | 52,391 | 38 d ago |
| Sep 4, 2026 | KYMR Kymera Therapeutics, Inc. | SOpen-market sale Common Stock | -2,137 | $117.57 | $251k | 50,254 | 38 d ago |
| Sep 3, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Common Stock | +52,500 | $0.00 | $0 | 52,500 | Sep 3, 2025 |
| Sep 3, 2025 | KYMR Kymera Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +105,000 | $0.00 | $0 | 105,000 | Sep 3, 2025 |
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,637 | $3.74 | $6,122 | 389,748 | Jul 30, 2025 |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -18,276 | $3.68 | $67k | 371,472 | Jul 30, 2025 |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,644 | $3.17 | $5,211 | 404,328 | Apr 30, 2025 |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -12,943 | $3.00 | $39k | 391,385 | Apr 30, 2025 |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -298 | $2.84 | $846 | 405,972 | Mar 31, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -33,688 | $4.63 | $156k | 287,920 | Jan 30, 2025 |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Common Stock | +139,141 | $0.00 | $0 | 427,061 | Jan 30, 2025 |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -20,791 | $4.42 | $92k | 406,270 | Jan 30, 2025 |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +275,000 | $0.00 | $0 | 275,000 | Jan 14, 2025 |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -299 | $4.38 | $1,310 | 321,608 | Dec 31, 2024 |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | SOpen-market sale Common Stock | -1,632 | $6.06 | $9,890 | 321,907 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.